Home Top Stories
Australia’s Dying Middle Class: The Rise of an Inherited Wealth Nation
Australia's middle class is shrinking — and inherited wealth is filling the gap. The middle class i…
Blog
Home Top Stories
These Lithium Stocks Are Sitting on Some of the World’s Rarest Cesium Assets
Most people have never heard of cesium. That’s partly what makes it so valuable. It’s a…
Home Top Stories
Aeris High-Grade Copper Results Strengthen Tritton Growth Outlook
Avoca Tank and Budgerygar deliver exceptional drill intercepts, highlighting strong copper continui…
Home Top Stories
CSL Interim CEO Review Flags FY26 Financial Update
CSL Limited cuts FY26 revenue and NPATA guidance on 11 May 2026, citing headwinds across key produc…
Home Top Stories
Elevra Lithium Cashes Out of Ewoyaa as Huayou Sweeps Up Ghana’s Lithium Future
Elevra Lithium is walking away from Ghana's most significant lithium development, pocketing US$71 m…
Home Top Stories
Cornish Metals Secures $210 Million Bond to Revive South Crofty Tin Mine
Cornish Metals has secured a $210 million bond financing, marking a watershed moment for the UK's d…
Home Top Stories
Two Vanguard ETFs on the ASX That Could Strengthen Any Long-Term Portfolio This May
VAE and V500 offer Australian investors broad exposure beyond local banks and miners.
Home Top Stories
Inside Warren Buffett’s 70-Year Wealth-Building Journey: How to Grow Wealth in Any Market
From selling gum as a child to building Berkshire Hathaway into a trillion-dollar giant, Warren Buf…
Home Top Stories
Australia Tightens Crypto Rules as AUSTRAC Targets Firms Ahead of 2026 Deadlines
Australia's financial intelligence agency escalates oversight of virtual asset service providers as…
Home Top Stories
Lynx Equity Picks Intel Over AMD as Apple Chip Deal Reshapes the AI Chip Race
Intel surged 14% on Apple chip deal news as AMD hit a one-year high on record Q1 earnings.
Homepage
Alphabet Stock Forecast Strengthens After Q1 Double-Beat
Alphabet Stock Forecast gains momentum after a strong Q1 2026 double-beat. Wall Street analysts rea…
Home Top Stories
Moderna Stock Climbs to Two-Month High on Hantavirus Vaccine Development News
Moderna shares jumped 18.6% to US$57.55 on renewed interest in its hantavirus vaccine development.